CN101007123B - Medicinal composition for treating and relieving rhinitis - Google Patents
Medicinal composition for treating and relieving rhinitis Download PDFInfo
- Publication number
- CN101007123B CN101007123B CN200610008484XA CN200610008484A CN101007123B CN 101007123 B CN101007123 B CN 101007123B CN 200610008484X A CN200610008484X A CN 200610008484XA CN 200610008484 A CN200610008484 A CN 200610008484A CN 101007123 B CN101007123 B CN 101007123B
- Authority
- CN
- China
- Prior art keywords
- herba
- rhinitis
- treatment
- petiolus trachycarpi
- mel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating rhinitis and process for preparation, wherein the constituents include Xanthium sibiricum, centipeda, flower bud of lily magnolia, Chinese ephedra, mentha,gen-seng, astragalus root, root of red rooted saliva, smoked plum, palmitic charcoal, black nightshade, Chinese honey locust and bee honey.
Description
Affiliated technical field the present invention relates to a kind of pharmaceutical composition for the treatment of and improving rhinitis and preparation method thereof.
Background technology
At present, that sell on the market or common have a hot temperature cold expelling, the rhinitis medicine of functions such as clear the nasal passage, especially the acute and chronic medicine with allergic rhinitis of treatment and auxiliary treatment, have following shortcoming to a certain extent: 1, Western medicine is taken toxic and side effects in various degree: 2, the Chinese medicine uncertain therapeutic efficacy is cut.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of and improving acute and chronic and allergic rhinitis and preparation method thereof, overcome the shortcoming that present Drug therapy rhinitis causes toxic and side effects in various degree.
The objective of the invention is to finish by the following technical programs:
The present invention is a kind of pharmaceutical composition for the treatment of and improving rhinitis, comprises following parts by weight of component: Fructus Xanthii 1-1000, Herba Centipedae 1-1000, Flos Magnoliae 1-1000, Herba Ephedrae 1-1000, Herba Menthae 1-1000, Radix Ginseng 1-1000, Radix Astragali 1-1000, Radix Salviae Miltiorrhizae 1-1000, Fructus Mume 1-1000, charred Petiolus Trachycarpi 1-1000, Herba Solani Nigri 11-1000, Spina Gleditsiae 1-1000, Mel 1-1000.
Described component is preferably following parts by weight of component: Fructus Xanthii 670, Herba Centipedae 250, Flos Magnoliae 330, Herba Ephedrae 140, Herba Menthae 230, Radix Ginseng 130, the Radix Astragali 310, Radix Salviae Miltiorrhizae 230, Fructus Mume 65, charred Petiolus Trachycarpi 50, Herba Solani Nigri 240, Spina Gleditsiae 250, Mel 5.
Described pharmaceutical composition is a said dosage form on any pharmaceutics.
Described pharmaceutical composition is preferably nasal drop.
A kind of preparation of drug combination method for the treatment of and improving rhinitis of the present invention, may further comprise the steps: get above 13 flavors, charred Petiolus Trachycarpi is ground into impalpable powder; Flos Magnoliae, Herba Centipedae, Herba Ephedrae, Herba Menthae add the water distillation, and distillate is standby.Medicinal residues after the distillation and water and all the other Fructus Xanthii seven flavors merge the decoction secondary, and filtrate concentrates, and stirs evenly, leave standstill, filter, filtrate and distillate merge, add charred Petiolus Trachycarpi impalpable powder, Mel and adjuvant, make said dosage form on any pharmaceutics, and can use prior art
Solution of the present invention is based on motherland's medical science to rhinitis, especially to understanding and Therapeutic Principle acute and chronic and allergic rhinitis treatment mechanism, achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out and have hot temperature cold expelling, the natural plant of clear the nasal passage is by the monarch prescription of theory of Chinese medical science, make various dosage forms, make its performance therapeutic efficiency.
Medicine material of the present invention all can be buied from market, selects the top grade raw material for use.
Effect of the present invention and indication: have hot temperature cold expelling, the effect of clear the nasal passage is used for the treatment and the auxiliary treatment of various acute and chronic and allergic rhinitises.
The present invention has the following advantages:
1, determined curative effect, therapeutic effect is remarkable.
2, overcome the shortcoming that present Drug therapy rhinitis causes toxic and side effects in various degree.
3, medicament sources is easy to get, at the bottom of the cost.
4, select natural plant for use, have no side effect.
For proof medicine of the present invention described therapeutic effect, from year April in March, 1997-2002, choose acute and chronic and allergic rhinitis 345 routine clinical observations, age 10-60 year.Stochastic sampling is divided into two groups, this medicine group 215 examples wherein, and M-F is at random.Therapeutic outcome shows efficient 100%.
Claims (2)
1. the pharmaceutical composition for the treatment of and improving rhinitis is characterized in that being made up of following raw materials according and weight ratio: Fructus Xanthii 670, Herba Centipedae 250, Flos Magnoliae 330, Herba Ephedrae 140, Herba Menthae 230, Radix Ginseng 130, the Radix Astragali 310, Radix Salviae Miltiorrhizae 230, Fructus Mume 65, charred Petiolus Trachycarpi 50, Herba Solani Nigri 240, Spina Gleditsiae 250, Mel 5.
2. pharmaceutical composition for the treatment of and improving rhinitis, the preparation of drug combination method that it is characterized in that this treatment and improve rhinitis may further comprise the steps: get Fructus Xanthii 670 by weight, Herba Centipedae 250, Flos Magnoliae 330, Herba Ephedrae 140, Herba Menthae 230, Radix Ginseng 130, the Radix Astragali 310, Radix Salviae Miltiorrhizae 230, Fructus Mume 65, charred Petiolus Trachycarpi 50, Herba Solani Nigri 240, Spina Gleditsiae 250, Mel 5; Charred Petiolus Trachycarpi is ground into impalpable powder; Flos Magnoliae, Herba Centipedae, Herba Ephedrae, Herba Menthae add the water distillation, distillate is standby, medicinal residues after the distillation and water and all the other Fructus Xanthii seven flavors merge the decoction secondary, and filtrate concentrates, and stirs evenly, leave standstill, filter, filtrate and distillate merge, and add charred Petiolus Trachycarpi impalpable powder, Mel and adjuvant, make said dosage form on any pharmaceutics, and can use excipient of the prior art.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610008484XA CN101007123B (en) | 2006-01-25 | 2006-01-25 | Medicinal composition for treating and relieving rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610008484XA CN101007123B (en) | 2006-01-25 | 2006-01-25 | Medicinal composition for treating and relieving rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101007123A CN101007123A (en) | 2007-08-01 |
| CN101007123B true CN101007123B (en) | 2011-08-10 |
Family
ID=38695934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610008484XA Active CN101007123B (en) | 2006-01-25 | 2006-01-25 | Medicinal composition for treating and relieving rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101007123B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106668304A (en) * | 2017-03-27 | 2017-05-17 | 皖南医学院 | Traditional Chinese medicine composition for treating rhinitis and application thereof |
| CN107158077A (en) * | 2017-06-02 | 2017-09-15 | 郑瑞龙 | The formula and preparation method of a kind of allergic rhinitis external preparation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099641A (en) * | 1994-03-02 | 1995-03-08 | 江洪彪 | Medicinal liquid for treating rhinitis and preparation method thereof |
| CN1115237A (en) * | 1994-07-18 | 1996-01-24 | 黄德棠 | Special effective medicine for rhinitis |
| CN1290537A (en) * | 2000-08-17 | 2001-04-11 | 万德富 | Chinese medicine suppository for rhinitis |
-
2006
- 2006-01-25 CN CN200610008484XA patent/CN101007123B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099641A (en) * | 1994-03-02 | 1995-03-08 | 江洪彪 | Medicinal liquid for treating rhinitis and preparation method thereof |
| CN1115237A (en) * | 1994-07-18 | 1996-01-24 | 黄德棠 | Special effective medicine for rhinitis |
| CN1290537A (en) * | 2000-08-17 | 2001-04-11 | 万德富 | Chinese medicine suppository for rhinitis |
Non-Patent Citations (1)
| Title |
|---|
| 姚练武等.中医药治疗过敏性鼻炎进展.《湖南中医药导报》.2002,第8卷(第2期),52-53. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101007123A (en) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129620A (en) | Traditional Chinese medicine for treating nasosinusitis headache | |
| CN103393966B (en) | A kind of Chinese medicine composition for the treatment of menoxenia | |
| CN101637546B (en) | Medicine for treating acute and chronic rhinitis and sinusitis | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN103656543A (en) | Chinese patent medicine granules for treating common cold due to wind-cold | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN101129636A (en) | Medicine for treating nasal inflammation | |
| CN102416071B (en) | Medicinal composition with effect of treating insomnia, preparation method and application of medicinal composition | |
| CN104367632A (en) | Small prescription for treating cold | |
| CN101007123B (en) | Medicinal composition for treating and relieving rhinitis | |
| CN102309617A (en) | Traditional Chinese medicine decoction for treating prosopalgia | |
| CN100998679A (en) | Traditional Chinese medicine preparation for treating rhinitis and nasal obstruction | |
| CN100998733B (en) | Oral traditional Chinese medicine for treating trigeminal neuralgia of prolonged illness entering subsidiary channels type | |
| CN103599179A (en) | Traditional Chinese medicine for treating kidney stone | |
| CN104083700A (en) | A traditional Chinese medicine composition treating woman algomenorrhea | |
| CN102743658B (en) | Traditional Chinese medicinal composition for treating urticaria | |
| CN103006780B (en) | Traditional Chinese medicinal composition for treating allergic rhinitis and method for preparing same | |
| CN102048930A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
| CN103394064A (en) | Traditional Chinese medicine composition used for treating slight cold | |
| CN1994437A (en) | Orally administered Chinese medicine for treating cold | |
| CN104257798A (en) | Traditional Chinese medicine formula for treating common cold | |
| CN104225039A (en) | Traditional Chinese medicine composition for treating wind-heat common cold | |
| CN102920873A (en) | Traditional Chinese medicine formula for treating gout | |
| CN1244367C (en) | 'Dianjian' liqid for curing epilepsy sickness | |
| CN101904962B (en) | Medicament for treating cold and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070801 Assignee: Guangxi Nanning Dezhi Pharmaceutical Industry Co., Ltd. Assignor: Su De Contract record no.: 2012450000079 Denomination of invention: Medicinal composition for treating and relieving rhinitis Granted publication date: 20110810 License type: Exclusive License Record date: 20121115 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |